| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 462,015 | 526,208 | 464,134 | 476,360 | | Cost of Revenue | 259,341 | 288,420 | 276,145 | 293,370 | | | Gross Profit | 202,674 | 237,788 | 187,989 | 182,990 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 172,595 | 173,896 | 179,213 | 185,550 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 30,079 | 63,892 | 8,776 | (2,560) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 289 | 231 | 258 | 333 | | Earnings Before Interest And Taxes | 30,368 | 64,123 | 9,034 | (2,227) | | Interest Expense | 308 | 231 | 418 | 683 | | Income Before Tax | 30,060 | 63,892 | 8,616 | (2,910) | | Income Tax Expense | 10,375 | 24,407 | 3,360 | (4,399) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 19,685 | 39,485 | 5,256 | 1,489 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,685 | 39,485 | 5,256 | 1,489 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $19,685 | $39,485 | $5,256 | $1,489 |
|
0.51% Nasdaq 
Income Statement
